Vagistat-1 (tioconazole) ointment is now approved for OTC use

    Vagistat-1 (tioconazole) ointment is now approved for OTC use. It's the first SINGLE-dose OTC treatment for vaginal yeast infections.

    Vagistat-1 is comparable to using Terazol 3 (terconazole) or Monistat 7 (miconazole).

    Tioconazole levels persist for 3 to 5 days after one dose.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

  • 12 issues every year — what you need to know and do, right now
  • Quick, practical reference charts and tools
  • Comprehensive CE library to meet license renewal and state requirements
  • Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
  • Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote